MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 103 filers reported holding MAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $960,919 | -32.0% | 307,987 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $1,413,660 | -7.3% | 307,987 | 0.0% | 0.01% | -7.7% |
| Q1 2023 | $1,524,536 | +114613.0% | 307,987 | +26.5% | 0.01% | +44.4% |
| Q4 2022 | $1,329 | -99.9% | 243,384 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $1,582,000 | +37.4% | 243,384 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $1,151,000 | -32.3% | 243,384 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $1,701,000 | -65.7% | 243,384 | -50.0% | 0.01% | -27.3% |
| Q4 2021 | $4,960,000 | +66.9% | 486,768 | +100.0% | 0.01% | -26.7% |
| Q3 2021 | $2,972,000 | – | 243,384 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $17,608,500 | 11.83% |
| Vitruvian Partners LLP | 5,043,356 | $27,536,724 | 5.80% |
| NORTH RUN CAPITAL, LP | 451,960 | $2,467,702 | 5.67% |
| Casdin Capital, LLC | 9,505,000 | $51,897,300 | 4.02% |
| RIVER GLOBAL INVESTORS LLP | 1,648,238 | $8,749 | 1.88% |
| Pier Capital, LLC | 1,074,164 | $5,864,935 | 0.96% |
| Montanaro Asset Management Ltd | 929,000 | $4,915,460 | 0.80% |
| First Light Asset Management, LLC | 1,365,343 | $7,454,773 | 0.69% |
| Stonepine Capital Management, LLC | 273,287 | $1,492,147 | 0.63% |
| Mudita Advisors LLP | 90,201 | $492,498 | 0.43% |